Sponsored Content

What Should You Consider When Scaling Fill/Finish for Cell and Gene Therapy?
Jim Sanford
WMFTS hero image

Transitioning from lab manufacture to commercialization presents significant challenges, no matter what area you’re working in. Cell and gene therapies are no different and production quantities must scale at multiple stages, first to support clinical trials and then when they reach the market. With uniquely challenging conditions required to protect medicinal integrity and exceptionally high value products this growing therapy class offers new challenges, but a combination of new technologies and a forward-thinking approach can help to mitigate these.

About Watson-Marlow Fluid Technology Solutions 

WMFTSWatson-Marlow Fluid Technology Solutions (WMFTS) is a world leader in the manufacture of peristaltic pumping solutions and associated fluid path technologies.

Download White Paper

To download this white paper, complete the form below. Once submitted, you will receive a link via the email you provided to download the white paper.

Company Type

By completing this form, you consent to have your information provided to the third-party sponsor of this content and may use your information to provide information about relevant products, services, and other opportunities which may be of interest to you . ISPE will store your information in a secure environment and may use your information to provide information about relevant products, services, and other opportunities which may be of interest to you. You may unsubscribe from these ISPE communications at any time. For more information or to unsubscribe, review our Privacy Policy or contact us at ask@ispe.org.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Product Development
Adv Manuf
ATMPs
Supply Chain

About the Author

Jim Sanford
Sector Manager for Biopharm Fluid Path
Watson-Marlow
Jim Sanford is the Sector Manager for Biopharm Fluid Path at Watson-Marlow and also serves on BioPhorum Supply Partner committees to help develop best practices...